MXPA04003631A - Rosuvastatina en estados de pre-demencia. - Google Patents
Rosuvastatina en estados de pre-demencia.Info
- Publication number
- MXPA04003631A MXPA04003631A MXPA04003631A MXPA04003631A MXPA04003631A MX PA04003631 A MXPA04003631 A MX PA04003631A MX PA04003631 A MXPA04003631 A MX PA04003631A MX PA04003631 A MXPA04003631 A MX PA04003631A MX PA04003631 A MXPA04003631 A MX PA04003631A
- Authority
- MX
- Mexico
- Prior art keywords
- rosuvastatin
- demented
- states
- patient
- dementia
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title abstract 3
- BPRHUIZQVSMCRT-VEUZHWNKSA-N rosuvastatin Chemical compound CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C=2C=CC(F)=CC=2)=C1\C=C\[C@@H](O)C[C@@H](O)CC(O)=O BPRHUIZQVSMCRT-VEUZHWNKSA-N 0.000 title abstract 2
- 229960000672 rosuvastatin Drugs 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0103509A SE0103509D0 (sv) | 2001-10-19 | 2001-10-19 | Rosuvastatin in pre demented states |
| PCT/SE2002/001911 WO2003032995A1 (en) | 2001-10-19 | 2002-10-18 | Rosuvastatin in pre demented states |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04003631A true MXPA04003631A (es) | 2004-07-30 |
Family
ID=20285721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04003631A MXPA04003631A (es) | 2001-10-19 | 2002-10-18 | Rosuvastatina en estados de pre-demencia. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20060229321A1 (https=) |
| EP (1) | EP1446123A1 (https=) |
| JP (1) | JP2005505605A (https=) |
| KR (1) | KR20040058201A (https=) |
| CN (1) | CN1604780A (https=) |
| AR (1) | AR036891A1 (https=) |
| BR (1) | BR0213434A (https=) |
| CA (1) | CA2463597A1 (https=) |
| CO (1) | CO5580773A2 (https=) |
| HU (1) | HUP0401798A3 (https=) |
| IL (1) | IL161380A0 (https=) |
| IS (1) | IS7218A (https=) |
| MX (1) | MXPA04003631A (https=) |
| NO (1) | NO20041840L (https=) |
| PL (1) | PL369573A1 (https=) |
| RU (1) | RU2004112422A (https=) |
| SE (1) | SE0103509D0 (https=) |
| WO (1) | WO2003032995A1 (https=) |
| ZA (1) | ZA200402844B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005023778A2 (en) | 2003-08-28 | 2005-03-17 | Teva Pharmaceutical Industries Ltd. | Process for preparation of rosuvastatin calcium |
| GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
| EP1601658A1 (en) | 2003-11-24 | 2005-12-07 | Teva Pharmaceutical Industries Limited | Crystalline ammonium salts of rosuvastatin |
| US7244844B2 (en) | 2003-12-02 | 2007-07-17 | Teva Pharmaceutical Industries Ltd. | Reference standard for characterization of rosuvastatin |
| WO2006017357A1 (en) | 2004-07-13 | 2006-02-16 | Teva Pharmaceutical Industries Ltd. | A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step |
| KR101020024B1 (ko) | 2005-02-22 | 2011-03-09 | 테바 파마슈티컬 인더스트리즈 리미티드 | 로수바스타틴 알킬에테르를 함유하지 않는 로수바스타틴 및이의 염 및 이의 제조 방법 |
| WO2007022488A2 (en) | 2005-08-16 | 2007-02-22 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
| WO2012073256A1 (en) | 2010-11-29 | 2012-06-07 | Cadila Healthcare Limited | Salts of rosuvastatin |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2648897B2 (ja) * | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| US7189703B2 (en) * | 1998-01-09 | 2007-03-13 | Intracell, Llc | Treatment and diagnosis of alzheimer's disease |
| AR022462A1 (es) * | 1999-02-06 | 2002-09-04 | Astrazeneca Uk Ltd | Uso de un agente que disminuye el colesterol |
| US20030100493A1 (en) * | 2001-07-19 | 2003-05-29 | Sol Weiss | Sublingual use of inhibitors in the biosynthesis of cholesterol |
-
2001
- 2001-10-19 SE SE0103509A patent/SE0103509D0/xx unknown
-
2002
- 2002-10-17 AR ARP020103895A patent/AR036891A1/es not_active Application Discontinuation
- 2002-10-18 US US10/492,971 patent/US20060229321A1/en not_active Abandoned
- 2002-10-18 HU HU0401798A patent/HUP0401798A3/hu unknown
- 2002-10-18 CA CA002463597A patent/CA2463597A1/en not_active Abandoned
- 2002-10-18 MX MXPA04003631A patent/MXPA04003631A/es not_active Application Discontinuation
- 2002-10-18 PL PL02369573A patent/PL369573A1/xx not_active Application Discontinuation
- 2002-10-18 CN CNA028253477A patent/CN1604780A/zh active Pending
- 2002-10-18 IL IL16138002A patent/IL161380A0/xx unknown
- 2002-10-18 KR KR10-2004-7005585A patent/KR20040058201A/ko not_active Withdrawn
- 2002-10-18 BR BR0213434-9A patent/BR0213434A/pt not_active Application Discontinuation
- 2002-10-18 EP EP02783893A patent/EP1446123A1/en not_active Withdrawn
- 2002-10-18 WO PCT/SE2002/001911 patent/WO2003032995A1/en not_active Ceased
- 2002-10-18 RU RU2004112422/14A patent/RU2004112422A/ru not_active Application Discontinuation
- 2002-10-18 JP JP2003535798A patent/JP2005505605A/ja active Pending
-
2004
- 2004-04-13 IS IS7218A patent/IS7218A/is unknown
- 2004-04-15 ZA ZA200402844A patent/ZA200402844B/en unknown
- 2004-04-19 CO CO04035705A patent/CO5580773A2/es not_active Application Discontinuation
- 2004-05-05 NO NO20041840A patent/NO20041840L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003032995A8 (en) | 2004-06-03 |
| IL161380A0 (en) | 2004-09-27 |
| AR036891A1 (es) | 2004-10-13 |
| CA2463597A1 (en) | 2003-04-24 |
| IS7218A (is) | 2004-04-13 |
| HUP0401798A2 (hu) | 2005-01-28 |
| KR20040058201A (ko) | 2004-07-03 |
| EP1446123A1 (en) | 2004-08-18 |
| BR0213434A (pt) | 2004-11-09 |
| CN1604780A (zh) | 2005-04-06 |
| PL369573A1 (en) | 2005-05-02 |
| HUP0401798A3 (en) | 2005-06-28 |
| WO2003032995A1 (en) | 2003-04-24 |
| SE0103509D0 (sv) | 2001-10-19 |
| JP2005505605A (ja) | 2005-02-24 |
| US20060229321A1 (en) | 2006-10-12 |
| NO20041840L (no) | 2004-05-05 |
| RU2004112422A (ru) | 2005-04-10 |
| ZA200402844B (en) | 2005-01-24 |
| CO5580773A2 (es) | 2005-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL165264A (en) | Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases | |
| AU6473601A (en) | Gabapentin analogues for sleep disorders | |
| AU1227302A (en) | System and method for optimizing drug therapy for the treatment of diseases | |
| MY127290A (en) | New use of flibanserin | |
| GB0130677D0 (en) | Medicaments and novel compounds | |
| DE50201780D1 (de) | Halogensubstituierte aminodicarbonsäurederivate als arzneimittel zur behandlung von herz-kreislauf-erkrankungen | |
| NO20051892L (no) | Ny forbindelse | |
| MXPA04003631A (es) | Rosuvastatina en estados de pre-demencia. | |
| NO20051893L (no) | Ny forbindelse | |
| GB0020504D0 (en) | Therapeutic method | |
| DK0583271T3 (da) | Arylmorpholin, fremstilling og anvendelse | |
| GB2383537B (en) | Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith | |
| HK1046089A1 (zh) | 褪黑激素的治疗用途 | |
| EP0866711A4 (en) | METHOD FOR PREVENTING SLEEP APNOE | |
| TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
| DE50010234D1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
| BR0009080A (pt) | Método de tratamento da apnéia do sono | |
| DE60200160D1 (de) | Verwendung von Cilobradine oder pharmazeutisch akzeptablen Salze zur Behandlung oder Prävention von Herzversagen | |
| MEP5608A (xx) | Nova upotreba (r) – (-)-2-[5-(4-fluorofenil)-3-piridil- metilaminometil] - hromana i njegovih fiziološko prihvatljivi h soli | |
| AU9545701A (en) | Use of carp inhibitors for the treatment of heart diseases | |
| WO2002015894A3 (en) | Use of vitamin d derivatives as bone resorption inhibitors | |
| DE60315666D1 (de) | Furopyridin- und furopyrimidinderivate zur behandlung von hyperproliferativen erkrankungen | |
| ATE341323T1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
| AU2002211217A1 (en) | Method of treating stroke | |
| DE60316927D1 (de) | Verwendung von devazepide als schmerzmittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |